ArticleMolecular biotechnology2026
Phytochemical-Mediated Synthesis of Zinc Oxide Nanoparticles with Enhanced Antimicrobial Properties.
Article in Molecular biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Biosynthesis of silver and gold nanoparticles usingBiomedical reports · 2026Article
- Novel Antimicrobial Composites Modified with Nanosilver, CuSOMaterials (Basel, Switzerland) · 2026Article
- Green Synthesis of ZnO Nanoparticles From Spirulina platensis: Antimicrobial and Cytotoxic Evaluation With Molecular Docking Studies.ChemistryOpen · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study explores the green synthesis of zinc oxide (ZnO) nanoparticles using phytochemicals from 21 different plant extracts and evaluates their antimicrobial efficacy. The plant-mediated method was compared with conventional chemical synthesis. Plant-mediated synthesized ZnO nanoparticles demonstrated enhanced antimicrobial activity against Escherichia coli and Staphylococcus aureus, with the most potent effects observed from Cinnamomum verum, Matricaria chamomilla, Mentha communis, Nicotiana rustica, Peganum harmala, Piper nigrum, and Syzygium aromaticum. No plant extract reduced the antimicrobial potency of ZnO particles. Plant extracts significantly influenced the physicochemical characteristics of nanoparticles, such as size, shape, surface charge, and colloidal stability. The characterization analyses confirmed successful functionalization and reduced particle size compared to chemically synthesized counterparts. These findings suggest that plant-derived phytochemicals can tailor ZnO nanoparticle properties to optimize antimicrobial performance, offering potential for environmentally friendly applications in healthcare and antimicrobial formulations.
Indexed as
Identifiers
41076492What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.